|About Us |Services | Research |Advisory Board |Contact Us |Home |

                       >> Search

Research & Development

Rational Drug Design
The main aim is to develop drugs through rational drug design, build software, databases and methodologies in the field of Proteomics and drug design. The main focus areas are Proteins in Tissue factor Pathway, Ligand design for G-Coupled receptors and HIV Integrase. & Identification of New Drug Targets & Development of Potential Drug for tuberculosis - An Innovative Approach - Visit our website for more info.

Mining of novel diagnostic markers and drug targets from Metabolic pathways:
The main objective of this project is to develop software tools for simulating/engineering the Metabolic Pathways of various diseases by using available full genome data, 3D- structural data of the proteins, metabolites, Enzymes etc to assign putative functions to genes by using various properties other than sequence similarity and the knowledge of existing generalized pathways will be superimposed to describe the pathways in a given organism. By doing so we are trying to establish potential diagnostic markers for various diseases and identify potential drug targets. The identified putative molecule would be further characterized in the wet-lab to establish its function.

C. Development of Protein Ligand database for Autoimmune diseases:
This project aims at creating a database which provides the complete information of Autoimmune Disease and their respective ligands. This database provides details about the autoimmune diseases. Involves the identification of the target regions. Involves the prediction of the structure of the receptors and Identification of the target drugs

D. Generation of Transgenic Cow resistant to Foot and Mouth disease:
The objective of the project is to develop a Transgenic cow, resistant to Foot and Mouth disease. Transgenic animals resistant to Foot and Mouth Disease Virus (FMDV) would not only prevent the virus from infecting the animal but also give rise to FMD resistant offspring from the transfected animals. Being an economical important disease the eradication of this disease will help the livestock owners to upgrade their livestock resulting in increased  milk production, meat production and quality hides and skins..

 | Clinical Research | NanoTech | Stem Cell Research | Publications | Events |
  We shall strive to offer high quality Service to all our Students / Partners / customers through optimum utilization of resources, technical excellence and a committed team. We adopt a comprehensive quality policy to ensure the highest standards for our products and services.  

  BRI is engaged in Research and Development, Offshore R&D Support and Bio utilities simulation & Development and Education. Our R&D Team specializes in improving and inventing techniques, methodologies and environments for research in Biotechnology. 

The Uniqueness about BRI is its advisory committee comprising of a large pool of about 25 Eminent Scientists and Research Scholars from various domains and from Major institutions, commercial organizations and Research Labs.
 
  The success of any project or Research ultimately rests on the people who implement the Project. Our greatest strength lies in the exceptional quality of our personnel. On numerous occasions we have been awarded contracts against stiff competition from much larger companies because of our outstanding team and their track record.

The team comprises of both young and dynamic as well as experienced Scientists and professionals. By having these people on staff, BRI can assure clients of consistent quality and superior technical skills.
 
     

Training Division offers PG Diploma in Bioinformatics - Duration - 3 Months. Correspondence Program is also avialable.

Industry-Institutional Collaboration Initiatives
BRI has tied up with reputed institutions, Pharmaceutical Companies and Well-Equipped Hospitals for Collaborative Research. These collaborative initiatives have provided BRI with the capability for undertaking high-end research with the assistance of trained professionals, academicians and utilizing the knowledge base available at their end.
 

  
BioWap
BioChat
BioSys
  

  

BRI is offering Unique Industry Standard Programs.As per estimates provided by 'ABLE' there is a potential in the BioTech industry for about 1 million new jobs by 2008.Click Here for More Information.

Login

Pwd

       






 

 
 
 

Legal
|
Security
|
Privacy